Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126628531 | 12662853 | 1 | I | 20160718 | 20160818 | 20160818 | EXP | US-STRIDES ARCOLAB LIMITED-2016SP010227 | STRIDES | JAIN AB, VENKATARAMANAN R, EGHTESAD B, MARCOS A, RAGNI M, SHAPIRO R, RAFAIL AB, FUNG JJ. EFFECT OF COADMINISTERED LOPINAVIR AND RITONAVIR (KALETRA) ON TACROLIMUS BLOOD CONCENTRATION IN LIVER TRANSPLANTATION PATIENTS. LIVER TRANSPLANTATION. 2003;9(9):954-960 | 0.00 | Y | 0.00000 | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126628531 | 12662853 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | 5 MG, BID | U | U | 90687 | 5 | MG | |||||||
| 126628531 | 12662853 | 2 | I | TACROLIMUS. | TACROLIMUS | 1 | 6 MG, PER DAY | U | U | 90687 | 6 | MG | |||||||
| 126628531 | 12662853 | 3 | I | TACROLIMUS. | TACROLIMUS | 1 | 0.5 MG, UNK | U | U | 90687 | .5 | MG | |||||||
| 126628531 | 12662853 | 4 | I | TACROLIMUS. | TACROLIMUS | 1 | 0.5 MG, ONCE A WEEK | U | U | 90687 | .5 | MG | |||||||
| 126628531 | 12662853 | 5 | I | KALETRA | LOPINAVIRRITONAVIR | 1 | UNK | 0 | CAPSULE | ||||||||||
| 126628531 | 12662853 | 6 | I | KALETRA | LOPINAVIRRITONAVIR | 1 | UNK | 0 | CAPSULE | ||||||||||
| 126628531 | 12662853 | 7 | C | LAMIVUDINE. | LAMIVUDINE | 1 | UNK | 0 | |||||||||||
| 126628531 | 12662853 | 8 | C | ZIDOVUDINE. | ZIDOVUDINE | 1 | UNK | 0 | |||||||||||
| 126628531 | 12662853 | 9 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 1 G, UNK | 0 | 1 | G | |||||||||
| 126628531 | 12662853 | 10 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 600 MG, UNK | 0 | 600 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126628531 | 12662853 | 1 | Immunosuppression |
| 126628531 | 12662853 | 5 | HIV infection |
| 126628531 | 12662853 | 7 | HIV infection |
| 126628531 | 12662853 | 8 | HIV infection |
| 126628531 | 12662853 | 9 | Immunosuppression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126628531 | 12662853 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126628531 | 12662853 | Drug interaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |